Curaleaf Holdings (CURLF) Other Working Capital Changes (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Other Working Capital Changes of -$7.1 million for Q4 2024, down 705.91% year-on-year from $1.2 million in Q1 2024, and down 166.42% on a QoQ basis from -$2.7 million in Q3 2024.

Curaleaf Holdings (CURLF) Other Working Capital Changes (2019 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Other Working Capital Changes for 6 consecutive years, with -$7.1 million the latest figure, recorded in Q4 2024.

  • Quarterly Other Working Capital Changes fell 705.91% year-over-year to -$7.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$12.1 million (down 6.23% YoY) and the FY2025 annual result came in at -$17.9 million, down 9.27% from the prior year.
  • Other Working Capital Changes declined to -$7.1 million in Q4 2024 per CURLF's latest filing, from -$2.7 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for CURLF reached as high as $13.8 million in Q4 2023 and fell as low as -$15.9 million in Q1 2021.
  • A 5-year average of -$649875.0 and a median of $566500.0 in 2020 frame the typical range for Other Working Capital Changes.
  • Annual changes were most pronounced in 2020 — Other Working Capital Changes sank 1682.44% — and 2021, when it soared 1958.42%.
  • Year by year, Other Working Capital Changes stood at -$23.2 million in 2020, then surged by 109.67% to $2.2 million in 2021, then soared by 1189.5% to $29.0 million in 2022, then plunged by 103.04% to -$880000.0 in 2023, then plunged by 705.91% to -$7.1 million in 2024.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$7.1 million, -$2.7 million, and -$880000.0 for Q4 2024, Q3 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.09 Mn
Dec 31, 2024 -2.09 Mn
Dec 31, 2024 -2.09 Mn
Sep 30, 2024 1.77 Mn
Sep 30, 2024 1.77 Mn
Sep 30, 2024 1.77 Mn
Dec 31, 2023 13.79 Mn
Dec 31, 2023 13.79 Mn
Dec 31, 2023 13.79 Mn
Sep 30, 2023 549,000.00
Sep 30, 2023 549,000.00
Sep 30, 2023 549,000.00
Dec 31, 2022 -2.23 Mn
Dec 31, 2022 -2.23 Mn
Dec 31, 2022 -2.23 Mn
Sep 30, 2022 3.36 Mn
Sep 30, 2022 3.36 Mn
Sep 30, 2022 3.36 Mn
Jun 30, 2022 3.71 Mn
Jun 30, 2022 3.71 Mn